# Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation

> **NCT05130268** · PHASE4 · COMPLETED · sponsor: **American Heart Association** · enrollment: 339 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** Dronedarone

## Key facts

- **NCT ID:** NCT05130268
- **Lead sponsor:** American Heart Association
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-29
- **Primary completion:** 2024-01-31
- **Final completion:** 2024-06-30
- **Target enrollment:** 339 (ACTUAL)
- **Last updated:** 2025-01-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05130268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05130268, "Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05130268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*